NCT05601583CompletedPhase 1
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
CP-CGMH: Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
Eligible older adults with Type 2 Diabetes-Mild Cognitive Impairment (T2D-MCI) will be provided a Continuous Glucose Monitoring (CGM) device and asked to share CGM data with their care partners for daily decision-making for diabetes self-management. After 2 weeks, individual interviews will be conducted in 20 participants (10 dyads). Older adults with T2D-MCI (n=10) and their care partners (n=10) will be interviewed separately to identify key features of the Care Partner-Assisted Intervention through linking continuous glucose monitoring and Mobile Health (CP-CGMH) app.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 27 Oct 2022
- Start date
- 19 Apr 2023
- Primary completion date
- 29 Aug 2023
- Lead sponsor
- NYU Langone Health
- Diseases
- Type 2 diabetes
- NCT number
- NCT05601583
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 14
- From 19 Apr 2023 to the primary completion date, 29 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have serious physical illness (e.g., end-stage renal disease);
- Presence of mental illness (e.g., schizophrenia or bipolar disorder) that would preclude participation.
- The care partners will be excluded if they:
Other
- Older adults who meet any of the following criteria will be excluded from participation in this study:
- Refuse or are unable to provide informed consent;
- Refuse or are unable to provide informed consent;
- Have MCI.
Who the study is looking for
- Older adults must meet all of the following criteria:
- be ≥ 65 years old;
- have had a diagnosis of T2D for at least one year;
- have MCI, defined as score 19-25 on the Montreal Cognitive Assessment (MoCA);60,61
- have a care partner (e.g., spouse or adult children);
- be willing to use CGM;
- be fluent in English.
- Eligible care partners must be:
- ≥ 18 years old;
- living with older adults with T2D-MCI;
- willing to be involved in patients' daily care;
- fluent in English.
Age in the registry: 65 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bellevue Hospital Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.